Dean Y. Li - Apr 21, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 21, 2023
Transactions value $
$0
Form type
4
Date filed
10/4/2023, 05:46 PM
Previous filing
Apr 5, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.66K +0.13% $0.00 1.33M Oct 2, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Gift $0 -628K -100% $0.00* 0 Apr 21, 2023 By Dean Y. Li 2021 GRAT F2
holding RXRX Class A Common Stock 1.42M Apr 21, 2023 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 450K Apr 21, 2023 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
F2 Reflects 687,295 shares transferred to the Reporting Person from the Dean Y. Li 2021 GRAT